Novo Nordisk Moves Into Renal Disease Via Pact With Omeros

 
• By Joseph Haas
  
Novo Nordisk
Novo Nordisk's 10th deal of 2025 brings a renal rare disease candidate • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business